Advertisement

Topics

Boehringer Ingelheum Company Profile

04:49 EST 14th December 2018 | BioPortfolio

Nil

Location

Av. del Libertador 7208
C1429BMS
Argentina

Contact

Phone: (011) 4704-8600
Fax: (011) 4704-8611
Email: info@bai.boehringer


News Articles [254 Associated News Articles listed on BioPortfolio]

PRESSESPIEGEL/Unternehmen: BOEHRINGER INGELHEIM, THYSSENKRUPP, COMMERZBANK, K+S, LUFTHANSA, 50HERTZ, DEUTSCHE GLASFASER, CISCO, HYPOVEREINSBANK

Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires. BOEHRINGER INGELHEIM - Der Pharmakonzern Boehringer Ingelheim strukturiert seine Wirkstoffproduktion um. ...

Boehringer to invest €230m in biologics R&D

Boehringer Ingelheim has revealed plans to invest €230m into a new Biologicals Development Center (BDC) set to be constructed at...Read More... The post Boehringer to invest €230m in biologics R&#...

Boehringer partners with Epizyme to develop new cancer therapies

Boehringer Ingelheim has formed a global alliance with US-based biopharmaceutical firm Epizyme for the research, development and commercialisation of new...Read More... The post Boehringer partners wi...

Boehringer expands drug manufacturing capabilities in China

Boehringer Ingelheim has added a new filling line to its Oasis facility in Shanghai, China in order to expand and...Read More... The post Boehringer expands drug manufacturing capabilities in China ap...

GSK poaches Boehringer veteran for drug development lead

Chris Corsico, currently chief medical officer at Boehringer, will start at GlaxoSmithKline in 2019 as the company changes up its research strategy.

Boehringer Ingelheim Partners with Epizyme

Boehringer Ingelheim and Epizyme announced a partnership on Thursday to develop oncology treatments.The partnership entails developing, researching and commercializing small molecule inhibitors direct...

Boehringer exercises option to buy ViraTherapeutics for $245m

Boehringer Ingelheim has acquired all of the shares in biopharmaceutical firm ViraTherapeutics for €210m ($245m) based on an option and...Read More... The post Boehringer exercises option to buy Vir...

Boehringer forms new alliance to develop gene therapy

Boehringer Ingelheim has entered a global partnership with the UK Cystic Fibrosis Gene Therapy Consortium (GTC), Imperial Innovations and Oxford...Read More... The post Boehringer forms new alliance t...

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Zantac [Boehringer Ingelheim Pharmaceuticals, Inc.]

Zantac Drug Facts

Zantac [Boehringer Ingelheim Pharmaceuticals, Inc.]

Zantac Drug Facts

Zantac [Boehringer Ingelheim Pharmaceuticals, Inc.]

Zantac Drug Facts

Dulcolax balance [Boehringer Ingelheim Pharmaceuticals Inc]

Boehringer-Ingelheim Consumer Health Care Products Dulcolax Balance® Drug Facts

Pradaxa [Boehringer Ingelheim Pharmaceuticals Inc.]

These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate mesylate) capsules for o...

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Boehringer-Ingelheim Satellite Symposium Choosing the Right Controller Therapy in Pediatric Patients with Asthma.

Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease.

Oral inhalation is the recommended delivery method of medications for the treatment of patients with chronic obstructive pulmonary disease (COPD). However, patients may struggle when using the various...

Establishment of a CFD-based k a model in microtiter plates to support CHO cell culture scale-up during clone selection.

Microtiter plates are a common tool for clone selection in biopharmaceutical development. A way of visualizing and evaluating these systems and key processes parameters is the application of Computati...

Clinical Trials [21 Associated Clinical Trials listed on BioPortfolio]

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

to evaluate the bioavailability of ambroxol hydrochloride soft pastilles (test formulation), manufactured by Bolder Arzneimittel GmbH & Co. KG to Boehringer Ingelheim compared to ambroxol ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions

The objective of this study was the bioequivalence of a Roxane Laboratories' Meloxicam tablets, 15 mg, to Mobic® Tablets, 15 mg (Boehringer Ingelheim) under fasting conditions using a sin...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Companies [39 Associated Companies listed on BioPortfolio]

Boehringer Ingelheum

Nil

Boehringer Ingelheim Pharmaceuticals Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group ...

Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim erforscht, entwickelt, produziert und vermarktet Arzneimittel für Menschen in aller Welt.Mit 37.406 Mitarbeitern, die in 143 Gesellschaften auf allen Kontinenten beschäftigt sin...

Boehringer Ingelheim Pharmaceuticals, Inc.

Metabolism is one of Boehringer Ingelheim's core R&D areas and diabetes is one of the indications at the center of interest within the company's global research network. Boehringer Ingelheim is commit...

Boehringer Ingelheim Corporation

Boehringer Ingelheim Corporation based in Ridgefield, CT, is the U.S. headquarters to seven subsidiaries and a member of the Boehringer Ingelheim group of companies.

More Information about "Boehringer Ingelheum" on BioPortfolio

We have published hundreds of Boehringer Ingelheum news stories on BioPortfolio along with dozens of Boehringer Ingelheum Clinical Trials and PubMed Articles about Boehringer Ingelheum for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Boehringer Ingelheum Companies in our database. You can also find out about relevant Boehringer Ingelheum Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record